The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...

The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.

The potential of biotech-powered consumer health is as sensitive as it is expansive. When it comes to consumer education, ...

E arly detection is imperative to catch neurodegenerative diseases like dementia in their early stages and slow disease ...